Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laboratorios Liomont SA de CV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0491
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, antiviral, antibiotic, anti-inflammatory, antifungal, anti-obesity, cardiovascular, gastroenterology, anti-diabetics, respiratory, urological, musculoskeletal, gastrointestinal and cardiometabolic, among others. Liomont sells its products through a network of distributors in Mexico, Columbia, Dominican Republic, Equador, El Salvador, Guatemala, Panama, Peru and Venezuela. The company operates through its manufacturing facility located in Mexico. Liomont is headquartered in Mexico City, Mexico.

Laboratorios Liomont SA de CV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Protein Sciences Enters into Licensing Agreement with Liomont for Flublok and Panblok 10
Oncobiologics Enters into Licensing Agreement with Liomont to Develop Biosimilar Monoclonal Antibody 12
Laboratorios Liomont Enters into Licensing Agreement with Selexis 13
Laboratorios Liomont SA de CV – Key Competitors 14
Laboratorios Liomont SA de CV – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Key Facts 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Liomont SA de CV, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Protein Sciences Enters into Licensing Agreement with Liomont for Flublok and Panblok 10
Oncobiologics Enters into Licensing Agreement with Liomont to Develop Biosimilar Monoclonal Antibody 12
Laboratorios Liomont Enters into Licensing Agreement with Selexis 13
Laboratorios Liomont SA de CV, Key Competitors 14
Laboratorios Liomont SA de CV, Other Locations 15

List of Figures
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios Liomont SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncolys BioPharma Inc (4588)-医療機器分野:企業M&A・提携分析
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OB …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MedImmune Ltd-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune Ltd (MedImmune), formerly Cambridge Antibody Technology Ltd, is a subsidiary of AstraZeneca Plc, is a research and development company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respi …
  • Fidelity National Information Services Inc:企業の戦略・SWOT・財務情報
    Fidelity National Information Services Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity National Information Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • The Quizno’s Master LLC:企業の戦略・SWOT・財務情報
    The Quizno’s Master LLC - Strategy, SWOT and Corporate Finance Report Summary The Quizno’s Master LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Petronas Dagangan Bhd (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • Helm AG:企業の戦略・SWOT・財務情報
    Helm AG - Strategy, SWOT and Corporate Finance Report Summary Helm AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Klockner Pentaplast GmbH & Co. KG:戦略・SWOT・企業財務分析
    Klockner Pentaplast GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Klockner Pentaplast GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Siemens Gamesa Renewable Energy SA (SGRE):電力:M&Aディール及び事業提携情報
    Summary Siemens Gamesa Renewable Energy SA (SGRE), formerly Gamesa Corporacion Tecnologica, S.A., is a supplier of wind power solutions. The company designs, manufactures and sells wind turbines. The product portfolio of the company includes offshore and onshore products. It also provides industry-l …
  • Ritter Pharmaceuticals Inc (RTTR):製薬・医療:M&Aディール及び事業提携情報
    Summary Ritter Pharmaceuticals Inc (Ritter) is a developer of therapeutic products for gastrointestinal diseases. The company’s lead product includes RP-G28, which is developed stimulate the growth of lactose-metabolizing bacteria in the colon to assist in digesting process. Its product is under the …
  • DLF Ltd:企業の戦略・SWOT・財務分析
    DLF Ltd - Strategy, SWOT and Corporate Finance Report Summary DLF Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • United States Steel Corp (X):企業の財務・戦略的SWOT分析
    United States Steel Corp (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Productos Medix SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Productos Medix SA de CV (Medix), formerly Laboratories Laif is a provider of research, development, manufacturing and marketing of pharmaceutical chemical products. The company’s products comprise livermade, pylopac, imidex, seronex, feprorex, MZ1, redotex, terfamex, prepram,sinestron, anta …
  • Tilaknagar Industries Ltd.:企業の戦略・SWOT・財務情報
    Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lombard Odier Private Clients:企業の戦略・SWOT・財務情報
    Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report Summary Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Municipal Energy Agency of Nebraska:発電所・企業SWOT分析
    Municipal Energy Agency of Nebraska – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • C.H. Robinson Worldwide Inc (CHRW):企業の財務・戦略的SWOT分析
    C.H. Robinson Worldwide Inc (CHRW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • HomeServe plc (HSV):企業の財務・戦略的SWOT分析
    HomeServe plc (HSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • SGL Carbon SE:企業の戦略・SWOT・財務分析
    SGL Carbon SE - Strategy, SWOT and Corporate Finance Report Summary SGL Carbon SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆